Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Med Care. 2017 Sep;55(9):864–870. doi: 10.1097/MLR.0000000000000781

Table 3.

Reclassification using common treatment cut-points.* Each cell represents the predicted risk group for each study participant by the different prediction techniques.

ASCVD Regression Recalibrated VARS-CVD
Low Medium High Low Medium High Total
Low (≤3%) 19,750 (24.4%) 61,340 (75.6%) 0 (0.0%) 78,195 (96.4%) 2,895 (3.6%) 0 (0.0%) 81,090
Medium (3–9%) 3,277 (1.4%) 230,173 (98.6%) 0 (0.0%) 46,494 (19.9%) 186,414 (79.9%) 542 (0.2%) 233,450
High (>9%) 0 (0.0%) 145,451 (76.8%) 44,030 (23.2%) 14 (0.01%) 118,538 (62.6%) 70,939 (37.4%) 189,491
*

Cut-points use 5-year cut-points of 3% and 9% 5-year risk, which closely approximate the 7.5% and 20% cut-points seen in current guidelines.